Empire State Development (New York) posted this RFP on Oct 21, 2026. Responses are due Nov 18, 2026. Category: Professional Services. Questions are due 2026-10-30. Solicitation number 2140115.
This bid was found on the agency's procurement portal. The portal's own text is not republished here; the summary below was written by ProposalWorkspace's AI from the bid documents. The full posting is on the portal - sign up free to get the link.
Summary fields on this page were extracted by AI from the bid documents. Always verify dates, amounts and requirements against the official solicitation.
ESD intends to establish a $45M NeuroCatalyst Commercialization Fund as part of its Bolstering Biotech Initiative to accelerate development and commercialization of life science research and innovations that address neurodegenerative diseases (ND), such as Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Motor Neuron Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis and others. The NeuroCatalyst Commercialization Fund (the “Fund”) is modeled after the successful Biodefense Commercialization Fund launched by the Life Science Initiative in 2021.
ESD is seeking competitive proposals for a qualified third-party firm (“Respondent”) to assist in the implementation of this Fund.
The Services to be performed will include, but are not limited to, overall hosting and management of application development, distribution, and processing; information sessions, outreach to and communications with prospective applicants and awardees; establishing an as-needed mentor program for grantees; identification and management of Expert Reviewers and Mentors; marketing the Fund; website and/or webcopy development and upkeep; and communications and outreach about the Fund to key stakeholders.
Under the direction of ESD, the Respondent will be responsible for the following:
**Submission method:** Proposals must be sent to the designated Dropbox: https://www.dropbox.com/request/5egtjip8yjh1jiw13mtc. Submission of proposals in a manner other than as described in these instructions (e.g., facsimile, hardcopies, emails) will not be accepted. Proposals deemed to arrive late will not be considered for award.
**Submission Deadline:** 2:00 PM ET on November 18, 2026
Submissions should be in Times New Roman with 12 pt font, and not to exceed 25 pages.
**Selection criteria** (maximum of 100 points):
Respondents should provide a proposed fee, broken down by year, for a 3-year contract likely starting in Q1 2027.
Interviews (if necessary): January 4-8, 2027. Anticipated Contract Start Date: January- February, 2027.
Sign up free to get these 4 documents.